COMP <GO>
EQIX vs JPM // ALTMAN Z-SCORE & DEBT/EQUITY
Equinix Inc. Common Stock REIT (NASDAQ) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: EQIX 4
— JPM 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: EQIX
LAST: $1,013.70 (-2.22%) • MKT CAP: $102.62B
balance-sheet
3.00
LAST: $337.04 (-1.90%) • MKT CAP: $895.92B
balance-sheet
0.37
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EQIX VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EQIX | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.30% | 17.37% | -11.07 | JPM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 50.8x | 9.7x | +41.13 | JPM | /valuation <GO> |
| Free Cash Flow Yield | 3.41% | -18.14% | +21.55 | EQIX | /fcf-yield <GO> |
| Operating Margin | 20.00% | 42.07% | -22.07 | JPM | /operating-margins <GO> |
| Net Profit Margin | 14.60% | 32.63% | -18.03 | JPM | /net-margins <GO> |
| Revenue Growth (YoY) | 5.40% | 13.53% | -8.13 | JPM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.81% | 1.96% | -0.15 | JPM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.00 | 0.37 | +2.63 | EQIX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 2/9 | +7.00 | EQIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 4.84% | +1.76 | JPM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.8 | 49.0 | +2.70 | EQIX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 1.00 | -0.09 | JPM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 70.7x | 13.6x | +57.13 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $102.62B | $895.92B | -$793.30B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EQIX REV | JPM REV | EQIX GROSS % | JPM GROSS % | EQIX FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.22B | $182.45B | 51.1% | — | $3.50B | -$147.78B |
| FY 2024 | $8.75B | $177.56B | 48.9% | — | $2.86B | -$42.01B |
| FY 2023 | $8.19B | $158.10B | 44.0% | — | $2.85B | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EQIX // BETA 0.91
JPM // BETA 1.00